From: Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study
2. Dependence on tumor location
Tumor location
MLD
CL0.5
Apical
3.1Â Gy
18.8%
Basal
3.4Â Gy
19.0%
Central
5.3Â Gy
31.3%